Drugs / Lactated ringers solution
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT07202559 Background | Oct 2025 → Dec 2027 expected | acute pancreatitis, chronic pancreatitis | Changhai Hospital | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Lactated ringers solution | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07202559 ↗ |
| Route | Intravenous | “Intravenous 20 mL/kg Ringer's lactate solution within 60 min from the start of ESWL, directly followed by 3 mL/kg per h for 8 h.” NCT07202559 ↗ |